Cassava Sciences Inc at B Riley Neuro & Ophthalmology Conference (Virtual) Transcript
Good afternoon and good morning to folks there on the West Coast. Welcome back to our next company presentation with Cassava Sciences -- I should say fireside chat actually -- with President and CEO, Remi Barbier; and Chief Financial Officer, Eric Schoen. Thank you both for joining us and being part of the conference. Appreciate you making time in your busy schedules.
Questions & Answers
So just to be frank, I'd be a little surprised if people were unaware of what's going on with Cassava, but I think if you could just maybe start at a high level, talking about Cassava's lead drug simufilam, some of your preclinical, clinical activity over the years, and sort of the potential in Alzheimer's disease.
Sure, Mayank. Great way to kick off the conference, and thank you for inviting us. Before we talk, we're a public company, so I need to go through a
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
